Agios Pharmaceuticals, Inc. · NASDAQ:AGIO

Dapice Joshua J. reported a 8.80% stake in Agios Pharmaceuticals, Inc. (Schedule 13G/A)

Event Dec 31, 2025 · Filed Feb 9, 2026

Dapice Joshua J. reported a 8.80% stake in Agios Pharmaceuticals, Inc., 5,159,505 shares, as a passive investor on Dec 31, 2025. Filed Feb 9, 2026 (Schedule 13G/A).

Stake
8.80%
Shares
5,159,505
Intent
Passive
What changed
Stake changed
Filed together
31 holders

The filing in full

HolderStakeShares
Farallon Capital Partners, L.P.0.70%413,359
Farallon Capital Institutional Partners, L.P.0.80%446,450
Farallon Capital Institutional Partners II, L.P.0.20%136,781
Farallon Capital Institutional Partners III, L.P.0.10%56,489
Four Crossings Institutional Partners V, L.P.0.20%97,883
Farallon Capital Offshore Investors II, L.P.1.60%904,525
Farallon Capital (AM) Investors, L.P.0.10%62,455
Farallon Capital F5 Master I, L.P.0.20%113,104
Farallon Healthcare Partners Master, L.P.5.00%2,928,459
Farallon Partners, L.L.C.8.70%5,046,401
Farallon Institutional (GP) V, L.L.C.0.20%97,883
Farallon F5 (GP), L.L.C.0.20%113,104
Farallon Healthcare Partners (GP), L.L.C.5.00%2,928,459
Dapice Joshua J.8.80%5,159,505
Dreyfuss, Philip D.8.80%5,159,505
Dunn Hannah E.8.80%5,159,505
Fried, Richard B0%0
Gehani, Varun N.8.80%5,159,505
Giauque, Nicolas8.80%5,159,505
Husen, Avner A.8.80%5,159,505
Kim, David T.8.80%5,159,505
Linn, Michael G.8.80%5,159,505
Luo Patrick (Cheng)8.80%5,159,505
Patel, Rajiv A.0%0
Roberts, Jr., Thomas G.8.80%5,159,505
Saito Edric C.8.80%5,159,505
Seybold, William0%0
Short Daniel S.8.80%5,159,505
Spokes, Andrew J. M.8.80%5,159,505
Warren, John R.8.80%5,159,505
Wehrly, Mark C.8.80%5,159,505

Source

View original at SEC

Related